glp 1 and bipolar disorder Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? Is tirzepatide (dual GIP/GLP‑1 receptor
Description
"Now that GLP-1based therapies have been shown to increase the risk of pancreatic inflammation and abnormal cell proliferation, further studies are needed to urgently clarify whether these linkages lead to pancreatic cancer with long-term use." Study co-authors, in addition to Butler and Atkinson, are Alexandra E
Some people find that splitting their dose helps maintain more consistent appetite suppression throughout the week
Validation at microdose levels does not
Insulin sensitizers in 2023: lessons learned and new avenues for investigation
M2, muscarinic acetylcholine receptor subtype 2
